Phosphorylated DSIP in hypoxia: a modified peptide and a specific model
Rats under simulated high-altitude conditions were assessed for sleep architecture, spatial memory and signaling after a phosphorylated DSIP intervention.
Rats under simulated high-altitude conditions were assessed for sleep architecture, spatial memory and signaling after a phosphorylated DSIP intervention.
02 / FINDINGS
What did the researchers report?
The modified peptide was associated with altered sleep stages, better task performance and changes in CREB-related measurements.
03 / INTERPRETATION
What are the limits?
The tested molecule was phosphorylated DSIP, not necessarily ordinary DSIP. Simulated hypoxia in rats does not establish treatment of human insomnia or cognitive impairment.
Original editorial summary by Sulan Peptide. Based on the source abstract; consult the full paper for methods, analyses, funding and disclosures.
RESEARCH CONTEXT
These are original reading notes on published studies, not product testimonials. Clinical studies used their own pharmaceutical formulations and protocols; their findings do not establish the safety, efficacy or equivalence of materials in our catalog. No personal-use or treatment guidance is provided.
